Accessibility Menu
 

TerrAscend

(OTC) TSNDF

Current Price$0.57
Market Cap$176.17M
Since IPO (2017)-53%
5 Year-95%
1 Year+18%
1 Month-18%

TerrAscend Financials at a Glance

Market Cap

$176.17M

Revenue (TTM)

$260.56M

Net Income (TTM)

$86.23M

EPS (TTM)

$-0.29

P/E Ratio

-1.99

Dividend

$0.00

Beta (Volatility)

0.95 (Low)

Price

$0.57

Volume

697,410

Open

$0.62

Previous Close

$0.57

Daily Range

$0.53 - $0.67

52-Week Range

$0.23 - $1.45

TSNDF: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About TerrAscend

Industry

Pharmaceuticals

Employees

1,038

CEO

Ziad Ghanem, PharmD

Headquarters

King of Prussia, PA 19406, US

TSNDF Financials

Key Financial Metrics (TTM)

Gross Margin

51%

Operating Margin

15%

Net Income Margin

-32%

Return on Equity

-25%

Return on Capital

8%

Return on Assets

-15%

Earnings Yield

-50.25%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$176.17M

Shares Outstanding

308.53M

Volume

697.41K

Short Interest

0.00%

Avg. Volume

306.11K

Financials (TTM)

Gross Profit

$136.32M

Operating Income

$42.02M

EBITDA

$86.33M

Operating Cash Flow

$30.29M

Capital Expenditure

$12.03M

Free Cash Flow

$18.26M

Cash & ST Invst.

$37.78M

Total Debt

$256.49M

TerrAscend Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$59.45M

-20.0%

Gross Profit

$32.36M

-13.3%

Gross Margin

54.43%

N/A

Market Cap

$176.17M

N/A

Market Cap/Employee

$185.44K

N/A

Employees

950

N/A

Net Income

$2.49M

+107.8%

EBITDA

$20.36M

+84.1%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$218.71M

-0.3%

Accounts Receivable

$23.14M

+22.5%

Inventory

$34.05M

-30.2%

Long Term Debt

$239.30M

+1.8%

Short Term Debt

$17.19M

+54.3%

Return on Assets

-15.21%

N/A

Return on Invested Capital

8.46%

N/A

Free Cash Flow

$5.87M

+122.0%

Operating Cash Flow

$11.18M

+134.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
XVIPYXvivo Perfusion AB (publ)
$6.54+0.00%
CLAZFClaritas Pharmaceuticals, Inc.
$0.00+0.00%
PEXXFPT Tempo Scan Pacific Tbk
$0.09+0.00%
CCHWFColumbia Care Inc.
$0.94-21.71%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$167.52-0.02%
TQQQProShares Trust - ProShares UltraPro Qqq
$38.78-0.06%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$8.28+0.05%
QQQInvesco QQQ Trust
$562.58-0.02%

Questions About TSNDF

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.